- Home
- UDMY vs SYRE Comparison
UDMY vs SYRE Comparison
Compare UDMY & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UDMY
- SYRE
- Stock Information
- Founded
- UDMY 2009
- SYRE 2013
- Country
- UDMY United States
- SYRE United States
- Employees
- UDMY N/A
- SYRE N/A
- Industry
- UDMY Other Consumer Services
- SYRE Biotechnology: Pharmaceutical Preparations
- Sector
- UDMY Real Estate
- SYRE Health Care
- Exchange
- UDMY Nasdaq
- SYRE Nasdaq
- Market Cap
- UDMY 904.2M
- SYRE 841.4M
- IPO Year
- UDMY 2021
- SYRE 2016
- Fundamental
- Price
- UDMY $7.32
- SYRE $15.30
- Analyst Decision
- UDMY Buy
- SYRE Buy
- Analyst Count
- UDMY 11
- SYRE 6
- Target Price
- UDMY $9.90
- SYRE $55.00
- AVG Volume (30 Days)
- UDMY 866.7K
- SYRE 490.0K
- Earning Date
- UDMY 07-30-2025
- SYRE 05-08-2025
- Dividend Yield
- UDMY N/A
- SYRE N/A
- EPS Growth
- UDMY N/A
- SYRE N/A
- EPS
- UDMY N/A
- SYRE N/A
- Revenue
- UDMY $790,019,000.00
- SYRE N/A
- Revenue This Year
- UDMY $1.87
- SYRE N/A
- Revenue Next Year
- UDMY $4.15
- SYRE N/A
- P/E Ratio
- UDMY N/A
- SYRE N/A
- Revenue Growth
- UDMY 5.43
- SYRE N/A
- 52 Week Low
- UDMY $5.68
- SYRE $10.91
- 52 Week High
- UDMY $10.61
- SYRE $40.26
- Technical
- Relative Strength Index (RSI)
- UDMY 58.35
- SYRE 51.16
- Support Level
- UDMY $6.70
- SYRE $14.87
- Resistance Level
- UDMY $7.50
- SYRE $15.71
- Average True Range (ATR)
- UDMY 0.25
- SYRE 0.72
- MACD
- UDMY 0.07
- SYRE 0.10
- Stochastic Oscillator
- UDMY 77.50
- SYRE 51.57
About UDMY Udemy Inc.
Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Consumer and Enterprise, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.